Grove Bank & Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $817K | Buy |
10,440
+662
| +7% | +$53.4K | 0.08% | 128 |
|
|
2026
Q1 | $847K | Sell |
9,778
-99
| -1% | -$9.48K | 0.1% | 124 |
|
|
2025
Q4 | $949K | Buy |
9,877
+386
| +4% | +$37.5K | 0.11% | 123 |
|
|
2025
Q3 | $904K | Sell |
9,491
-967
| -9% | -$88.9K | 0.11% | 120 |
|
|
2025
Q2 | $912K | Buy |
10,458
+439
| +4% | +$37.2K | 0.11% | 116 |
|
|
2025
Q1 | $900K | Buy |
10,019
+2
| +0% | +$179 | 0.12% | 112 |
|
|
2024
Q4 | $800K | Buy |
10,017
+704
| +8% | +$60.9K | 0.11% | 118 |
|
|
2024
Q3 | $838K | Sell |
9,313
-55
| -0.6% | -$4.63K | 0.12% | 107 |
|
|
2024
Q2 | $737K | Buy |
9,368
+672
| +8% | +$55.1K | 0.12% | 110 |
|
|
2024
Q1 | $758K | Buy |
8,696
+1,414
| +19% | +$121K | 0.13% | 105 |
|
|
2023
Q4 | $600K | Sell |
7,282
-730
| -9% | -$55.6K | 0.11% | 134 |
|
|
2023
Q3 | $628K | Buy |
8,012
+1,257
| +19% | +$105K | 0.13% | 124 |
|
|
2023
Q2 | $595K | Sell |
6,755
-347
| -5% | -$29.9K | 0.12% | 129 |
|
|
2023
Q1 | $573K | Buy |
7,102
+21
| +0.3% | +$1.71K | 0.12% | 128 |
|
|
2022
Q4 | $550K | Buy |
7,081
+4,351
| +159% | +$353K | 0.12% | 133 |
|
|
2022
Q3 | $220K | Sell |
2,730
-395
| -13% | -$35.5K | 0.05% | 196 |
|
|
2022
Q2 | $280K | Sell |
3,125
-282
| -8% | -$28.6K | 0.07% | 178 |
|
|
2022
Q1 | $378K | Sell |
3,407
-282
| -8% | -$29.8K | 0.07% | 170 |
|
|
2021
Q4 | $382K | Hold |
3,689
| – | – | 0.07% | 172 |
|
|
2021
Q3 | $462K | Sell |
3,689
-7,729
| -68% | -$1M | 0.1% | 148 |
|
|
2021
Q2 | $1.42M | Buy |
11,418
+7,904
| +225% | +$992K | 0.31% | 76 |
|
|
2021
Q1 | $415K | Buy |
3,514
+658
| +23% | +$77.1K | 0.1% | 147 |
|
|
2020
Q4 | $335K | Buy |
+2,856
| New | +$314K | 0.09% | 155 |
|
|
2020
Q1 | – | Sell |
-1,926
| Closed | -$219K | – | 175 |
|
|
2019
Q4 | $219K | Sell |
1,926
-121
| -6% | -$13.3K | 0.07% | 176 |
|
|
2019
Q3 | $222K | Buy |
+2,047
| New | +$214K | 0.07% | 166 |
|
|
2017
Q4 | – | Sell |
-358
| Closed | -$28K | – | 551 |
|
|
2017
Q3 | $28K | Sell |
358
-286
| -44% | -$23.7K | 0.01% | 360 |
|
|
2017
Q2 | $57K | Buy |
644
+358
| +125% | +$30.2K | 0.04% | 241 |
|
|
2017
Q1 | $23K | Hold |
286
| – | – | 0.02% | 288 |
|
|
2016
Q4 | $20K | Buy |
+286
| New | +$22.5K | 0.02% | 318 |
|
|
2016
Q1 | – | Sell |
-635
| Closed | -$49K | – | 311 |
|
|
2015
Q4 | $49K | Buy |
+635
| New | +$47.8K | 0.04% | 176 |
|
Other funds holding MDT
Grove Bank & Trust's MDT Position: Q2 2026 in Review
Grove Bank & Trust increased its Medtronic (MDT) stake by 6.8% in Q2 2026, buying an estimated $53.4K and bringing the position to 10,440 shares worth $817K. The position accounts for 0.08% of the portfolio, ranked #128.
Grove Bank & Trust first reported a position in MDT in Q4 2015 and has held it in 30 quarters since. The position peaked at $1.42M in Q2 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Grove Bank & Trust held 10,440 shares of Medtronic worth $817K as of Q2 2026.
- Grove Bank & Trust bought 662 Medtronic shares in Q2 2026, an estimated $53.4K.
- Medtronic made up 0.08% of Grove Bank & Trust's portfolio in Q2 2026, its #128 holding.
- Grove Bank & Trust first reported a position in Medtronic in Q4 2015 and has held it in 30 quarters since.
- Grove Bank & Trust's Medtronic position peaked at $1.42M in Q2 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.